Claire took on the route with her aim to raise funds for breast cancer patients in the Ulster Hospital who are undergoing ...

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...

AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), ...

Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...

Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community ...

Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...

Updated results from the KATHERINE trial showed that adjuvant T-DM1 provided a significant improvement in overall survival and no evidence of long-term safety issues.

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...